CDK Inhibitor p18INK4c Is a Downstream Target of GATA3 and Restrains Mammary Luminal Progenitor Cell Proliferation and Tumorigenesis
Xin‐Hai Pei(Chinese Academy of Medical Sciences & Peking Union Medical College), Yue Xiong(University of North Carolina at Chapel Hill), Matthew D. Smith(University of North Carolina at Chapel Hill), I‐Cheng Ho(Brigham and Women's Hospital), Charles M. Perou(University of North Carolina at Chapel Hill), Jerry Usary(University of North Carolina at Chapel Hill), Sung‐Yun Pai(Dana-Farber Cancer Institute), Cheng Fan(University of North Carolina at Chapel Hill), Feng Bai(Shanxi Medical University)
Cited by 113
Related Papers
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma
|Clinical Cancer Research|2004|2.7k
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
|Breast Cancer Research|2010|2.1k
The molecular portraits of breast tumors are conserved across microarray platforms
|BMC Genomics|2006|1.5k
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k